Stakeholders' perspectives on the regulation and integration of complementary and alternative medicine products in Lebanon: a qualitative study
- PMID: 21871124
- PMCID: PMC3175209
- DOI: 10.1186/1472-6882-11-71
Stakeholders' perspectives on the regulation and integration of complementary and alternative medicine products in Lebanon: a qualitative study
Abstract
Background: The regulation of the markets for Complementary and Alternative Medicine (CAM) products presents a global challenge. There is a dearth of studies that have examined or evaluated the regulatory policies of CAM products in the Eastern Mediterranean Region (EMR). We investigate the regulatory frameworks and the barriers for the proper regulation and integration of CAM products in Lebanon, as an example of an EMR country with a weak public infrastructure.
Methods: We utilized a qualitative study design involving a series of semi-structured interviews with stakeholders of the CAM market in Lebanon. Snowball sampling was used to identify interviewees; interviews continued until the "saturation" point was reached. A total of 16 interviews were carried out with decision makers, representatives of professional associations, academic researchers, CAM product importers, policy makers and a media representative. Interviews were transcribed and thematic analysis of scripts was carried out.
Results: There was a consensus among all stakeholders that the regulation of the market for CAM products in Lebanon needs to be strengthened. Thematic analysis identified a number of impediments jeopardizing the safety of public consumption and hindering the integration of CAM therapies into mainstream medicine; including: weak infrastructure, poor regulation, ineffective policies and politics, weak CAM awareness and sub-optimal coordination and cooperation among stakeholders. With respect to policy instruments, voluntary instruments (self regulation) were deemed ineffective by stakeholders due to poor awareness of both users and providers on safe use of CAM products. Stakeholders' rather recommended the adoption of a combination of mixed (enhancing public awareness and integration of CAM into medical and nursing curricula) and compulsory (stricter governmental regulation) policy instruments for the regulation of the market for CAM products.
Conclusions: The current status quo with respect to the regulation of CAM products in Lebanon is not conducive to public safety, nor does it support the integration of CAM products into the healthcare system. The Ministry of Health indeed plays a dominant role in the regulation of these products through a combination of mixed and compulsory policy instruments. Yet, the proper implementation of these regulations requires political resolve coupled with the cooperation of all CAM stakeholders.
Figures
Similar articles
-
A profession in danger: Stakeholders' perspectives on supporting the pharmacy profession in Lebanon.PLoS One. 2020 Nov 16;15(11):e0242213. doi: 10.1371/journal.pone.0242213. eCollection 2020. PLoS One. 2020. PMID: 33196652 Free PMC article.
-
Beliefs, practices and knowledge of community pharmacists regarding complementary and alternative medicine: national cross-sectional study in Lebanon.BMJ Open. 2019 Mar 8;9(3):e025074. doi: 10.1136/bmjopen-2018-025074. BMJ Open. 2019. PMID: 30852542 Free PMC article.
-
A triangulated perspective for understanding CAM use in Lebanon: a qualitative study.BMC Complement Med Ther. 2022 Aug 2;22(1):204. doi: 10.1186/s12906-022-03685-z. BMC Complement Med Ther. 2022. PMID: 35918687 Free PMC article.
-
Legal status and regulation of complementary and alternative medicine in Europe.Forsch Komplementmed. 2012;19 Suppl 2:29-36. doi: 10.1159/000343125. Forsch Komplementmed. 2012. PMID: 23883942 Review.
-
Complementary and integrative medical therapies, the FDA, and the NIH: definitions and regulation.Dermatol Ther. 2003;16(2):77-84. doi: 10.1046/j.1529-8019.2003.01614.x. Dermatol Ther. 2003. PMID: 12919107 Review.
Cited by
-
Understanding CAM Use in Lebanon: Findings from a National Survey.Evid Based Complement Alternat Med. 2018 Jul 25;2018:4169159. doi: 10.1155/2018/4169159. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30147730 Free PMC article.
-
Whose Knowledge? Examining the Relationship between the Traditional Medicine Sector and Environmental Conservation Using a Stakeholder Analysis: Perceptions on Warwick Herb Market Durban South Africa.Int J Environ Res Public Health. 2022 Sep 21;19(19):11900. doi: 10.3390/ijerph191911900. Int J Environ Res Public Health. 2022. PMID: 36231202 Free PMC article.
-
Protection of Rights of Knowledge Holders and Practitioners of Traditional Medicine in Tanzania.East Afr Health Res J. 2024;8(2):280-287. doi: 10.24248/eahrj.v8i2.791. Epub 2024 Jun 26. East Afr Health Res J. 2024. PMID: 39296768 Free PMC article.
-
Linking coping strategies to locally-perceived aetiologies of mental distress in northern Rwanda.BMJ Glob Health. 2020 Jul;5(7):e002304. doi: 10.1136/bmjgh-2020-002304. BMJ Glob Health. 2020. PMID: 32665374 Free PMC article.
-
Prevalence and Characteristics of CAM Use among People Living with HIV and AIDS in Lebanon: Implications for Patient Care.Evid Based Complement Alternat Med. 2016;2016:5013132. doi: 10.1155/2016/5013132. Epub 2016 Dec 6. Evid Based Complement Alternat Med. 2016. PMID: 28050191 Free PMC article.
References
-
- NIH: National Center for Complementary and Alternative Medicine. http://nccam.nih.gov/health/whatiscam/
-
- Harvey KJ, Korczak VS, Marron LJ, Newgreen DB. Commercialism, choice and consumer protection: regulation of complementary medicines in Australia. Med J Aust. 2008;188(1):21–25. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical